Ecological shifts of salivary microbiota associated with metabolic-associated fatty liver disease

Abstract

IntroductionMetabolic-associated fatty liver disease (MAFLD) is the most common chronic liver disease related to metabolic syndrome. However, ecological shifts in the saliva microbiome in patients with MAFLD remain unknown. This study aimed to investigate the changes to the salivary microbial community in patients with MAFLD and explore the potential function of microbiota.MethodsSalivary microbiomes from ten MAFLD patients and ten healthy participants were analyzed by 16S rRNA amplicon sequencing and bioinformatics analysis. Body composition, plasma enzymes, hormones, and blood lipid profiles were assessed with physical examinations and laboratory tests.ResultsThe salivary microbiome of MAFLD patients was characterized by increased α-diversity and distinct β-diversity clustering compared with control subjects. Linear discriminant analysis effect size analysis showed a total of 44 taxa significantly differed between the two groups. Genera Neisseria, Filifactor, and Capnocytophaga were identified as differentially enriched genera for comparison of the two groups. Co-occurrence networks suggested that the salivary microbiota from MAFLD patients exhibited more intricate and robust interrelationships. The diagnostic model based on the salivary microbiome achieved a good diagnostic power with an area under the curve of 0.82(95% CI: 0.61–1). Redundancy analysis and spearman correlation analysis revealed that clinical variables related to insulin resistance and obesity were strongly associated with the microbial community. Metagenomic predictions based on Phylogenetic Investigation of Communities by Reconstruction of Unobserved States revealed that pathways related to metabolism were more prevalent in the two groups.ConclusionsPatients with MAFLD manifested ecological shifts in the salivary microbiome, and the saliva microbiome-based diagnostic model provides a promising approach for auxiliary MAFLD diagnosis.

Distinctive subgingival microbial signatures in older adults with different levels of cognitive function

“…Oral microbiological samples are increasingly being used for the assessment of various diseases, such as gastric cancer and metabolic liver disease, because of their non-invasiveness and cost effectiveness (Huang et al, 2021;Wang et al, 2023). Oral microbiological disorders can contribute to the development of systemic diseases beyond the oral cavity, leading to long-term chronic inflammation (Atarashi et al, 2017;Leonardi et al, 2018;Read et al, 2021), involving cardiovascular (Koren et al, 2011;Mougeot et al, 2023), immune (Heron & Elahi, 2017), endocrine (Casarin et al, 2013) and neurological (Almarhoumi et al, 2023;Kamer et al, 2021;Werber et al, 2021) diseases.…”